CO-TRIMOXAZOLE Tablets

Composition: Each tablet contains:
Trimethoprim 80 mg\ Sulphamethoxazole 400 mg.
Indications:
CO-TRIMOXAZOLE shouhd be limited to the role of drug of choice in pneumocystis jirovecii (Pneumocysti carinii)
pneumonia: it is also indicated for toxoplasmosis and nocardiasis, It should now only be considered for use in
acute exacerbations of chronic bronchitis and infections of the urinary tract when there is good bacteriological
evidence of sensitivity to CO-TRIMOXAZOLE and good reason to prefer this combination to a single
antibacterial, similarly it should only be used in acute otitis media in children when there is good reason to
prefer it